Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2/PHASE3
38 participants
INTERVENTIONAL
2003-09-30
2004-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
NCT00140894
Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
NCT00808743
Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
NCT00141193
A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
NCT03649971
Testing Obeticholic Acid for Familial Adenomatous Polyposis
NCT05223036
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Rofexocib 25 mg OD, 1 year treatment
Rofecoxib
2
Placebo
placebo
placebo pills
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rofecoxib
placebo
placebo pills
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Malignancy
* NSAID hypersensitivity
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept of Medicine, Rikshospitalet
Oslo, Oslo County, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RH01/01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.